ABVC BioPharma Inc (ABVC)
1.05
-0.01
(-0.94%)
USD |
NASDAQ |
May 08, 14:03
ABVC BioPharma Cash from Financing (Quarterly): 0.0874M for Dec. 31, 2023
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 0.0874M |
| September 30, 2023 | 1.656M |
| June 30, 2023 | -0.0316M |
| March 31, 2023 | 2.207M |
| December 31, 2022 | -0.2535M |
| September 30, 2022 | 0.6035M |
| June 30, 2022 | 3.664M |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 4.253M |
| September 30, 2021 | 5.818M |
| June 30, 2021 | -0.117M |
| March 31, 2021 | 0.0422M |
| December 31, 2020 | 6.869M |
| September 30, 2020 | 0.4437M |
| June 30, 2020 | 1.645M |
| March 31, 2020 | 0.6104M |
| December 31, 2019 | 0.6042M |
| September 30, 2019 | 0.7517M |
| June 30, 2019 | 0.3577M |
| March 31, 2019 | 1.374M |
| December 31, 2018 | -0.0741M |
| September 30, 2018 | -0.1449M |
| June 30, 2018 | 0.4622M |
| March 31, 2018 | 0.3497M |
| September 30, 2017 | 0.52M |
| Date | Value |
|---|---|
| June 30, 2017 | 0.09M |
| March 31, 2017 | 0.95M |
| December 31, 2016 | 0.07M |
| September 30, 2016 | 0.30M |
| June 30, 2016 | 2.047M |
| March 31, 2016 | 0.0032M |
| December 31, 2015 | 0.3034M |
| September 30, 2015 | 0.00 |
| June 30, 2015 | 0.00 |
| March 31, 2015 | 0.00 |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.025M |
| September 30, 2012 | 0.0447M |
| June 30, 2012 | 0.3034M |
| March 31, 2012 | 0.1851M |
| December 31, 2011 | 0.3431M |
| September 30, 2011 | 0.30M |
| June 30, 2011 | 0.40M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.2535M
Minimum
Dec 2022
6.869M
Maximum
Dec 2020
1.537M
Average
0.6042M
Median
Dec 2019
Cash from Financing (Quarterly) Benchmarks
| NeuBase Therapeutics Inc | -0.1745M |
| Sutro Biopharma Inc | -3.125M |
| Reviva Pharmaceuticals Holdings Inc | 27.27M |
| Flora Growth Corp | 0.704M |
| Journey Medical Corp | 19.21M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.4795M |
| Cash from Investing (Quarterly) | 0.1542M |
| Free Cash Flow | -4.257M |
| Free Cash Flow Per Share (Quarterly) | -0.0606 |
| Free Cash Flow to Equity (Quarterly) | 0.5583M |
| Free Cash Flow to Firm (Quarterly) | 0.6456M |
| Free Cash Flow Yield | -87.26% |